Clinical trial
PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study…
NCT00043368 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00043368 |
|---|---|
| Title | PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) |
| Official title | A Continuation Study Of PF-3512676 (CPG 7909) Injection In Patients With Metastatic Or Recurrent Malignancies Who Have Stable Disease Or Who Have Responded To Pf-3512676 Injection Therapy |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma, Breast Neoplasms, Carcinoma, Renal Cell, Lymphoma, T-Cell, Non-Small-Cell Lung |
| Intervention type | Drug |
| Interventions | PF-3512676 |
| Enrollment | 31 |
| Start date | Sep 1, 2002 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Aug 12, 2002 |
| Last update posted | Mar 12, 2009 |
| Countries | Germany, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: